Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
11/05/1996 | US5571818 Pyrrolyl-4h-pyranoisoquinolines |
11/05/1996 | US5571813 Treatment of hypertension, congestive heart failure, renal failure |
11/05/1996 | US5571807 Calcium antagonists, treatment of angina and hypertension |
11/05/1996 | US5571792 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
11/05/1996 | US5571524 Diadenosine tetraphosphate |
11/05/1996 | US5571523 Antioxidant-induced apoptosis in vascular smooth muscle cells |
10/31/1996 | WO1996034010A2 Inhibitors of farnesyl-protein transferase |
10/31/1996 | WO1996033999A1 NOVEL SUBSTITUTED TETRAHYDROPYRANO[3,2-d]OXAZOLONES, METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
10/31/1996 | WO1996033993A1 Antithrombotic amidinotetrahydropyridylalanine derivatives |
10/31/1996 | WO1996033970A1 Substituted phenyl amidines, medicaments containing these compounds and process for producing them |
10/31/1996 | WO1996033740A1 Use of leukemia inhibitory factor and endothelin antagonists |
10/31/1996 | WO1996033730A2 Chemokine binding protein and methods of use therefor |
10/31/1996 | WO1996033726A1 Preparation and use of sulfated oligosaccharides |
10/31/1996 | WO1996033716A1 RARβ SELECTIVE RETINOID COMPOUNDS FOR INHIBITING GENE EXPRESSION PROMOTED BY AP1 PROTEIN AND THEIR USE IN THERAPY |
10/31/1996 | WO1996033715A1 Novel use of pyrazolopyridine compounds |
10/31/1996 | WO1996033713A1 Indazolecarboxamides |
10/31/1996 | WO1996033703A2 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy |
10/31/1996 | WO1996033696A1 Novel collagen formulations |
10/31/1996 | WO1996033678A1 Triacetin as a transdermal penetration enhancer |
10/31/1996 | DE19515500A1 Substituierte Phenylamidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Substituted phenylamidines, pharmaceutical compositions containing them and methods for their preparation |
10/31/1996 | CA2219571A1 Novel substituted tetrahydropyrano[3,2-d]oxazolones, method for their preparation and pharmaceutical compositions containing them |
10/31/1996 | CA2219337A1 Substituted phenylamidines, pharmaceutical compositions containing these compounds and processes for preparing them |
10/31/1996 | CA2219261A1 Antithrombotic amidinotetrahydropyridylalanine derivatives |
10/31/1996 | CA2219028A1 Rar.beta. selective retinoid compounds for inhibiting gene expression promoted by ap1 protein and their use in therapy |
10/31/1996 | CA2218037A1 Novel collagen formulations |
10/31/1996 | CA2217696A1 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy |
10/31/1996 | CA2215359A1 Indazolecarboxamides |
10/30/1996 | EP0739892A2 Chromone derivatives |
10/30/1996 | EP0739629A1 Associations comprising (-)hydroxycitrate and having new therapeutical activities |
10/30/1996 | EP0739355A1 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof |
10/30/1996 | EP0739342A1 Pyridine modulators of acetylcholine receptors |
10/30/1996 | EP0739336A1 Gem-disubstituted azacyclic tachykinin antagonists |
10/30/1996 | EP0739200A1 Therapeutic substituted guanidines |
10/30/1996 | EP0552379B1 Dihydropyridine derivatives, and process for their preparation |
10/30/1996 | EP0532595B1 The pharmacological use of certain cystine derivatives |
10/30/1996 | CN1134706A Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same |
10/30/1996 | CN1134705A Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases |
10/30/1996 | CN1134669A Use of thiazolidinediones to prevent or delay onset of NIDDM |
10/30/1996 | CN1134665A Novel pharmaceutical composition containing the ACE inhibitor ramipril and a dihydropyridine compound |
10/30/1996 | CN1134423A Adhesion receptor antagonists |
10/30/1996 | CN1134421A Substituted thiophenesulfonylureas and-thioureas, processes for their preparation, their use as medicament or diagnostic, and medicament containing them |
10/30/1996 | CN1134417A 2,8-disubstituted quinazolinones |
10/30/1996 | CN1134415A Substituted benzene sulfone urea, benzenesulfonyl thiourea, its preparing method application of preparation for producing medicine and drugs containing them |
10/30/1996 | CN1134414A Substituted benzene sulfone urea, benzenesulfonyl thiourea its preparation, its application as medicine or diagnostic medicine and drugs containing it |
10/30/1996 | CN1134413A 4-Mercaptobenzoylguanidine derivatives |
10/30/1996 | CN1134295A Oral medicine for treating acute cerebrovascular disease |
10/29/1996 | US5569768 Angiotensin II antagonists |
10/29/1996 | US5569657 (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]-hydrazono]propanedinitrile |
10/29/1996 | US5569647 Angiopeptin cyclopeptide compounds |
10/29/1996 | CA2057912C (1,2n) and (3,2n)-carbocyclic-2-amino tetralin derivatives |
10/29/1996 | CA1338683C Fatty acid therapy and compositions |
10/24/1996 | WO1996033282A2 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations |
10/24/1996 | WO1996033281A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations |
10/24/1996 | WO1996033268A1 Apopain |
10/24/1996 | WO1996033175A1 Cyclic amidino agents useful as nitric oxide synthase inhibitors |
10/24/1996 | WO1996033170A1 N-aroylamino acid amides as endothelin inhibitors |
10/24/1996 | WO1996033166A1 Hydroxamic and carboxylic acids as metalloprotease inhibitors |
10/24/1996 | WO1996033159A1 Cyclobutane derivatives as inhibitors of squalene synthase and protein farnesyltransferase |
10/24/1996 | WO1996032966A1 Arteriovenous and venous graft treatments: methods and compositions |
10/24/1996 | WO1996032954A1 Nitrosylated neuropeptides |
10/24/1996 | WO1996032906A1 Magnesium taurate as a therapeutic agent |
10/24/1996 | WO1996032841A1 Novel therapeutic binding molecule complexes |
10/24/1996 | WO1996029315A3 Imidazole derivatives as histamine receptor h3 (ant)agonists |
10/24/1996 | CA2218716A1 N-aroylamino acid amides as endothelin inhibitors |
10/24/1996 | CA2218691A1 Novel therapeutic binding molecule complexes |
10/24/1996 | CA2218679A1 Apopain |
10/24/1996 | CA2218597A1 Cyclobutane derivatives as inhibitors of squalene synthase and protein farnesyltransferase |
10/24/1996 | CA2218380A1 Novel hydroxamic and carbocylic acids as metalloprotease inhibitors |
10/24/1996 | CA2216882A1 Cyclic amidino agents useful as nitric oxide synthase inhibitors |
10/24/1996 | CA2216871A1 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations |
10/24/1996 | CA2216868A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations |
10/24/1996 | CA2215631A1 Arteriovenous and venous graft treatments: methods and compositions |
10/23/1996 | EP0738712A1 Anti-arrhythmic and cardioprotective substituted indenoylguanidines |
10/23/1996 | EP0738512A1 Use of a HMG CoA reductase inhibitor to prevent a second heart attack |
10/23/1996 | EP0738280A1 Superactive vip antagonists |
10/23/1996 | EP0738270A1 Dihydro pyrazolopyrroles |
10/23/1996 | EP0738269A1 Novel piperidine derivatives with paf antagonist activity |
10/23/1996 | EP0738267A1 Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
10/23/1996 | EP0738156A1 Methods and compositions for inhibiting thrombogenesis |
10/23/1996 | EP0738151A1 Treatment using arachidonic acid metabolite and particulate formulations |
10/23/1996 | EP0738150A1 Bicyclic fibrinogen antagonists |
10/23/1996 | EP0600950B1 Amide tetrazole acat inhibitors |
10/23/1996 | EP0517876B1 Therapeutic benzazepine compounds |
10/23/1996 | EP0416094B1 Parathyroid hypertensive factor |
10/23/1996 | CN1134151A Pyrazine carboxamide derivs., their production and their use in medicaments |
10/23/1996 | CN1134150A Quinazoline deriv. |
10/23/1996 | CN1134149A Phenylindole compounds |
10/23/1996 | CN1134148A Antithrombotic amidinophenylalanine and amidinopyridylalanine derivs |
10/23/1996 | CN1134146A Benzoyl guanidines, their production and their use in medicaments |
10/23/1996 | CN1134108A Beads for controlled release and pharmaceutical preparation contg. same |
10/23/1996 | CN1133844A Osa-or thia-aliphatically bridged quinoxaline-2,3-diones |
10/23/1996 | CN1133843A Thienopyridone |
10/23/1996 | CN1133839A Aroyl-piperidine derivatives |
10/23/1996 | CN1133837A Substituted 1H-imidazoles |
10/23/1996 | CN1133709A Process for preparing controlled-release tablet of diltiazem hydrochloride |
10/22/1996 | US5567841 α-phosphonosulfonate squalene synthetase inhibitors and method |
10/22/1996 | US5567828 For treatment of post-menopausal diseases, i.e., osteoporosis, cardiovascular disorders, cancer |
10/22/1996 | US5567824 Catalyzing the cyclization in presence of a solvent and a proton acceptor |
10/22/1996 | US5567814 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE |
10/22/1996 | US5567765 Artificial blood, contrast agent, organ preservative |